Where Do We Stand with Medical Therapy Versus Intervention in Stable Patients with Ischemia

Monday, February 27, 2023

4:53 PM – 5:01 PM ET

Speaker(s)

Rasha Al-Lamee, MA, MD, PhD

Interventional Cardiology Consultant
Imperial College London
London, England, United Kingdom

Disclosure(s): Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)

Disclosure(s):

Rasha Al-Lamee, MA, MD, PhD: Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)